Increased tumor-specific CTL activity in human tumor-infiltrating lymphocytes stimulated with autologous tumor lines
- 31 July 1991
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 135 (2) , 526-533
- https://doi.org/10.1016/0008-8749(91)90295-m
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Predominant Expression of T Cell Receptor V α 7 in Tumor-Infiltrating Lymphocytes of Uveal MelanomaScience, 1990
- The use of microcapsules for high density growth of human tumor infiltrating lymphocytes and other immune reactive T cellsJournal of Immunological Methods, 1990
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma.The Journal of Experimental Medicine, 1988
- Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.The Journal of Experimental Medicine, 1988
- Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.Journal of Clinical Oncology, 1988
- Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clonesEuropean Journal of Immunology, 1988
- Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trialsJournal of Immunological Methods, 1987
- Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon γInternational Journal of Cancer, 1986
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986